Bioorganic and Medicinal Chemistry p. 1349 - 1355 (2001)
Update date:2022-08-05
Topics:
Kumagai, Toshihito
Okubo, Taketoshi
Kataoka-Okubo, Hiromi
Chaki, Shigeyuki
Okuyama, Shigeru
Nakazato, Atsuro
Recently, various non-peptide corticotropin-releasing factor1 (CRF1) receptor antagonists have been reported. Structure-affinity relationships (SARs) of non-peptide CRF1 antagonists suggest that such antagonists can be constructed of three units: a hydrophobic unit (Up-Area), a proton accepting unit (Central-Area), and an aromatic unit (Down-Area). We previously presented 4-aryl-1,2,3,6-tetrahydropyridinopyrimidine derivatives including potent CRF receptor ligands 1a and 1b and proposed that the 4-aryl-1,2,3,6-tetrahydropyridino moiety might be useful as a substituent in the Up-Area. Our interest shifted to 5-aryl-1,2,3,6-tetrahydropyridinopyrimidine derivatives 2, among which compound 2m (CRA0165) had highest affinity for CRF1 receptors (IC50=11 nM). We report here the design, synthesis and SARs of derivatives 2.
View MoreContact:+86-310-7092106
Address:Quzhou Modern & New Industrial Park, Handan, Hebei 057250, China
website:http://www.uvchemkeys.com
Contact:0086-021-58785816
Address:RM2607 Building No.1 Guosheng, Lane 388, Zhongjiang Road, Putuo District, Shanghai 200062 China
Contact:13357117572
Address:No.149 Shiji dadao Road.
Huangshan Violet Biological Technology Co., Ltd
Contact:+86-559-2335676
Address:16-201 JinShanYuan,JiangNan New City,TunXi District,HuangShan City,AnHui Province,China
Jinan Baozhao Pharmaceutical Co., Ltd
Contact:0086-531-86397156 82371858 82371868
Address:Huaneng Road, Jinan, Shandong ,China
Doi:10.1016/j.bmcl.2006.08.022
(2006)Doi:10.1016/j.bmcl.2007.06.082
(2007)Doi:10.1021/ja00292a068
(1985)Doi:10.1271/bbb.67.2556
(2003)Doi:10.1016/j.molstruc.2006.11.071
(2007)Doi:10.1016/j.bmcl.2010.05.013
(2010)